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Abstract 
 
 
Background: Paraben exposure occurs everyday to most people unknowingly. Parabens are 
present in most personal care products in varying amounts. Presently, parabens are not listed as 
endocrine disruptors; however, some research has shown parabens associated with decreases in 
thyroid hormone levels. The chemical and adsorption mechanism for parabens in association with 
thyroid hormones is not well understood. Determining whether parabens are associated with a 
change in thyroid hormone levels can help reduce the incidence of possible adverse health effects 
with exposure to parabens. 
 
Methodology: The selected study variables were analyzed using SAS version 9.2. Data were 
obtained from the 2007-2008 National Health and Nutrition Examination Survey (NHANES). 
Analyses were performed separately for adolescent females (12-19) and adult females (20+). 
Weighted means were performed for the main independent and dependent variables of interest 
stratified by race/ethnicity groups and by smoking status. Independent samples t-test and ANOVA 
was used to test significance of differences of weighted means. Weighted bivariate linear regression 
was performed for each dependent variable (Thyroid Stimulating Hormone [TSH], Triiodothyronine 
[T3], and Thyroxine [T4]) regressed on butylparaben. Weighted multiple linear regressions were 
performed and parameter estimates with 95% confidence intervals were used to ascertain the 
measure of effect. Separate regression models stratified by age group (adolescent vs. adult) were ran 
for each dependent variable (TSH, T3, and T4) regressed on butylparaben level and covariates, 
race/ethnicity and smoking status (ever smoked).  
 
Results: Weighted bivariate linear regression showed that among adult females, for each ng/ml 
increase in butylparaben, there was a -1.07 decrease in ng/dL T3 (p<. 05) levels. Among adult 
females, for each ng/ml increase in butylparaben was associated with a -0.12 decrease in ug/dL T4 
(p<. 01) levels. Butylparaben was not predictive of TSH (p=. 15), T3 (p=. 79), or T4 (p=. 07) levels 
in adolescent females, whereas butylparaben in adult females was not predictive of TSH (p=. 55) 
levels.  
 
Weighted multiple linear regression showed higher butylparaben levels among adult females were 
associated with 0.12 ug/dL lower than average T4 levels (p<. 01) controlling for race/ethnicity and 
smoking status; however, no association was found among adolescent females. Mexican American 
adult females had 0.17mIU/L lower than average TSH levels compared to other race adult females 
(p<. 001), whereas, other Hispanic adolescent females had 0.3 mIU/L higher than normal TSH levels 
compared to other race adolescent females (p<. 05) and other Hispanic adult females had 0.12mIU/L 
higher TSH levels compared to other race adult females (p<. 05), controlling for butylparaben and 
smoking status. Other Hispanic adult females showed 0.03 ng/dL lower than average T3 levels 
compared to other race adult females (p<. 05) whereas other Hispanic adolescent females showed 
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0.67 ug/dL lower than average T4 levels compared to other race adolescent females (p<. 0001), 
controlling for butylparaben and smoking status. Non-Hispanic Black female adolescents had 0.44 
ug/dL higher than average T4 levels compared to other race adolescent females (p<. 05) whereas 
non-Hispanic black adults showed a 0.28 ug/dL higher than average T4 levels compared to other 
race adult females (p=. 05), controlling for butylparaben and smoking status. Ever smoking status 
was not associated with any of the thyroid hormone measures. 
 
Conclusion: While parabens are currently not considered endocrine disruptors, the human 
metabolism of and effects from exposure to parabens are not well understood. Results from this 
study showing decreased levels of some thyroid hormone levels (TSH, T3, and T4) associated with 
increased levels of butylparaben was found, as well as differences in thyroid hormone levels among 
racial/ethnic groups. Although not many human studies have found significant results, 10 some 
rodent studies have found butylparaben associations with thyroid hormone changes.4, 6, 19, 54 The 
results of this study indicating no statistically significant association between butylparaben and 
decreases in thyroid hormone levels are consistent with results of some rodent studies.7, 8, 54, 55 In 
light of these findings, additional human studies with paraben exposure and thyroid hormone levels 
are needed to increase knowledge of the mechanism and effect of parabens in the human body. 
 
 
Key Words: Butylparaben, Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), 
Thyroxine (T4), NHANES, Female, Cross-sectional, Ever Smoking, Race/Ethnicity. 
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Chapter I 
Introduction 
 
1a. Background 
 
Parabens, widely used for their antibacterial properties, are found in many personal care products. 
Parabens are an ester of parahydroxybenzoic acid. It is believed that the pharmaceutical industry first 
used parabens as preservatives in the 1920s. Over the decades since its introduction, parabens have 
found their way into many products used daily such as cosmetics, hair products, lotions, shaving 
products, etc. Parabens are sometimes used in food and drink products, especially canned goods, to 
help preserve the product and create a longer shelf life.  
 
Starting in the early 1990s the fear of possible endocrine disrupting powers of parabens began, due 
to articles suggesting negative health effects from pesticides and other man-made chemicals.1-4 In 
vivo and in vitro studies soon followed; an overview of these studies will be covered in the literature 
review. To date, it is uncertain whether or not parabens cause endocrine disruption in humans. Many 
rodent studies have shown estrogenic tendencies, whereas some others have shown small to no 
estrogenic effect. 5-9 Few human paraben studies have been completed, 10-12 also with conflicting 
results.  
 
A small number of natural or chemical compounds have been scientifically proven to create 
endocrine disruption including, diethylstilbesterol (DES), dioxin, polychlorinated biphenyls (PCBs), 
DDT, and some other pesticides. 13 Endocrine disruption causes interference with the normal 
functioning of the endocrine system. Thyroid hormones, which control many bodily functions 
including growth, development, and reproduction, are very important to human homeostasis. 
Thyroid hormones are also incredibly important for fetus and child development, without which 
could cause detrimental developmental effects. The long-term, low-dose effect of paraben exposure 
is not known, nor has it been studied, thus the risk for negative human health effects is unknown.14  
 
1b. Purpose of Study 
 
The purpose of this study was to examine the association between butylparaben exposure and 
thyroid function in females age 12 and over, in a nationally representative, human population. This 
topic is important to public health because of the everyday use of products that contain parabens 
such as cosmetics and foods. Past studies have shown parabens associated with breast cancer as well 
as damage to sperm cells. The Cosmetic Ingredient Review Expert Panel (CIR) concluded that 
parabens are safe as cosmetic ingredients. However the anti-paraben movement has recently led 
many cosmetic companies to remove parabens from their products. Overall, increasing the 
knowledge of the scientific community on the possible harmful effects of parabens is the main 
objective of my study. In order to more fully examine the role of parabens in relation to thyroid 
2	  
 levels this study aims to use a nationally representative dataset to show the association of urine 
paraben levels with blood thyroid levels. 
 
 
1c. Hypothesis 
 
H1: Butylparaben will be associated with decreases in thyroid hormone levels (TSH, T3, and T4). 
H0: Butylparaben will not be associated with decreases in thyroid hormone levels (TSH, T3, and 
T4). 
 
This study examined the research question of whether butylparaben levels in urine was associated 
with blood thyroid hormone levels (TSH, T3, and T4) in females aged 12 and over in the National 
Health and Nutrition Survey from 2007-2008. Specifically, the central hypothesis of this study is that 
butylparaben will cause thyroid hormone levels to decrease. Previous studies showed that analyzing 
data among two separate age groups, adolescents aged 12-19 and adults age 20 and over, was 
warranted due to differing thyroid activity among age groups.10 The results of some studies suggest 
that parabens might be thyroid hormone receptor agonists.15, 16 Ever smoking and race/ethnicity were 
controlled for in the analyses; women who were pregnant, taking birth control, and who had thyroid 
problems were excluded from the study due to differing levels of thyroid hormones caused by each 
factor. Race/ethnicity was adjusted for when estimating the association between butylparaben and 
thyroid hormone levels. 
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Chapter II 
Literature Review 
 
The literature review contains compiled research from various studies on paraben exposure and 
thyroid levels as well as the estrogenic and endocrine disrupting effects of parabens. This review 
also is composed of an overview of parabens, the endocrine system, and thyroid hormones. The 
literature review is designed to help understand parabens, how they work, and what effects they have 
on human health.  
 
2a. Overview of Parabens 
 
Parabens are man-made chemicals that are considered esters of p-hydroxybenzoic acid. Parabens are 
one of the most commonly used preservatives in personal care products, foods, beverages, and 
pharmaceuticals. Parabens are readily used throughout the world due to their low cost and low 
toxicity. Methylparaben, propylparaben, and butylparaben are the most frequently used in personal 
care products. The use of more than one paraben or similar preservative within a product is common 
practice. With the use of multiple preservatives smaller doses can be used while increasing the 
preservative effect. Preservatives, such as 
parabens, are used in products to prevent 
growth of microbials and to maintain the 
integrity of the product. The first usage of 
parabens date back to 1920 when the 
pharmaceutical industry used them as 
preservatives.10 The chemical structures of 
a basic paraben as well as butylparaben, 
the main paraben of interest for this study, 
are shown in Figures 1 and 2.  
 
2b. Legislation of Parabens 
 
In the United States, parabens are not widely legislated. The Food and Drug Administration (FDA) 
does not regulate ingredients in cosmetics, where a majority of parabens can be found. Color 
additives are the only ingredient that may be regulated by the FDA under The Federal Food, Drug, 
and Cosmetic Act (FD&C Act). 18 In comparison, many other countries, including the European 
Union (EU) countries and Japan, have limits on the amount by mass of parabens allowed in cosmetic 
products: 0.4% for a single paraben and 0.8% for multiple parabens in EU countries,  and 1.0% total 
paraben concentration in Japan.19 Increasing concern about endocrine disruption from man-made 
chemicals has lead to a review of the toxicity of parabens. The Cosmetic Ingredient Review expert 
panel examined the safety assessment of parabens in 2008. After reviewing hundreds of references 
on parabens the panel concluded that parabens are safe to use. The panel set no-observed adverse 
Figure 2: Butylparaben 
Structure17	  
C11H14O3  	  	  	  	  
Figure 1: Basic 
Paraben Structure 
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effect levels (NOAEL’s) at 1.2mg/kg bw/day for adults and 0.3mg/kg bw/day for infants.20 In the 
European Union the Scientific Committee on Consumer Products (SCCP) concluded that 
methylparaben and ethylparaben are safe for use in cosmetics at up to 0.4% of the cosmetic 
concentration, with an acceptable daily intake (ADI) set at 10mg/kg/bw/day.20 Insufficient results 
were found for propyl-, isopropyl-, butyl-, and isobutylparaben, with no ADI set for these parabens. 
Butylparaben is not safe to be used in food products according to data collected by the WHO.21, 22 
Examining the regulation that other countries have placed on parabens in comparison to the United 
States, there is a need for product review programs to regulate parabens being used for human 
consumption. A sign of hope for paraben regulation is the formation of the United States Endocrine 
Disruptor Screening and Testing Advisory Committee (EDSTAC).23  
 
 
2c. Exposure to Parabens  
 
The most common exposure to parabens is through personal care products including but not limited 
to: makeup, moisturizers, hair-care products, shaving creams, pharmaceuticals, foods, drinks. A 
1995 study by Rastogi et al. analyzed 215 cosmetic products and found that 77% of rinse-off 
products contained parabens, while 99% of leave-on products contained parabens.24 Dodson et al. 
completed a study which tested 213 products for parabens; parabens were found in 10 products, 7 of 
which were from products where parabens were not found on the label.25 A study done by Rastogi 
found that 45% of skin creams were incorrectly labeled, while 10% of other products were 
mislabeled with respect to parabens.26 Retail cosmetics must declare ingredients on the packaging of 
the product, which helps to determine which products contain parabens. In Appendix 1 is a list of 
names used for each paraben.  
 
Humans are exposed to parabens via three routes: dermal, inhalation, and ingestion. The majority of 
personal care products enter the body through dermal exposure. While food and drink are the main 
sources of ingestion and air (and dust) is the main route for inhalation exposure, presumably from 
personal care product usage.27, 28 The amount of parabens found in indoor air and dust vary 
regionally, most likely due to differing consumption of paraben containing personal care products.27 
Parabens have also been found in ground water as well as waste water treatment facilities, most 
likely caused by run-off from daily usage of parabens.29 Daily estimates of paraben usage from 
cosmetic products for adults is 17.76g and 0.378g for infants, calculated by Błędzka, et al. from 
Cosmetic Ingredient Review panel estimates.19 The U.S. Food and Drug Administration’s Center for 
Food Safety and Applied Nutrition has estimated a consumption rate of 37 ng/day for 
butylparaben.30 Differences in daily exposure may be due to environmental factors.31 Environmental 
factors could include differences in climate, socioeconomic, cultrual, or demographic factors. These 
factors can change the amount of paraben containing products used. It has been found that women 
have higher rates of parabens found in their blood, most likely due to the amount of paraben 
containing perosnal care products used daily.11 Exposure to parabens for pregnant women is of 
special concern due to the possible negative effects to the unborn child.32 
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2d. Metabolism of Parabens in Humans 
 
Metabolism of parabens in the human body depends on the route of exposure. After oral exposure, 
the parabens travel to the gastrointestinal tract and blood where they are rapidly absorbed. It is 
thought that parabens are broken down by esterase, leading to hydrolysis; p-hydroxybenzoic acid 
(PHBA) is the main product that results from hydrolysis of parabens.33 The metabolized parabens 
are then excreted in urine and feces. The body excretes a majority of orally ingested parabens within 
the twenty-four hours following exposure.19 Dermal exposure also results in absorption into the 
blood stream and metabolism by esterase. Increased chain length of the paraben decreases the ability 
of the paraben to penetrate the skin.20 However, the metabolic rate of parabens is based on the 
amount of paraben that penetrates the skin; for example, butylparaben is hydrolysed at a higher rate 
when compared to propylparaben.34 Oral and dermal exposures both lead to absorption in the blood 
as well as the liver. In the liver the parabens are adjoined with glycine, sulfate, or glucuruonate, 
which aids in the breakdown of parabens for excretion in the urine.35 Parabens also have lipophilic 
characteristics that cause them to be absorbed and remain intact in human tissue. According to 
Aubert et al. results of a study on lab rats showed that 50% of dermally applied paraben was 
absorbed.36 The presence of intact parabens found in human excretions shows that they have escaped 
either skin or intestinal/liver metabolism.37  
 
Continuous dermal exposure to parabens may result in bioaccumulation according to a study by 
Ishiwatari et al.38 It has been shown that hydrolysis of parabens occurs more slowly in dermal 
exposure compared to exposure to the liver by route of ingestion.39 The slowed hydrolysis of 
dermally exposed parabens may be the reason for accumulation in the body. In comparison to oral 
and dermal absorption of parabens in the body, subcutaneous exposure creates a large exposure to 
parabens in the body due to the bypassing of hydrolysis in skin and gastrointestinal system.40 Figure 
3, shows the different human exposure to parabens and how they are metabolized in the body. 
Human metabolism data are lacking, particularly showing the fraction of excreted paraben versus the 
fraction of excreted p-hydroxybenzoic acid; which would aid understanding the differences in 
metabolism by exposure route.41 However, it is known that most of a paraben is excreted in a 
conjugated form, with some amount of parabens being excreted in the free form.42  
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Figure 3: Exposure and Metabolism Pathways of Parabens 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2e. Endocrine System 
 
The endocrine system controls many human bodily functions. The endocrine system produces 
hormones at various glands located in the body. The hormones then travel all over the body to 
maintain organs and tissues. The glands that release the hormones act as messengers to the receptors 
that collect and respond to the hormones. Reproduction, growth, sexual development, energy levels, 
bone and muscle strength, and homeostasis are some, but not all, of the areas that are governed by 
the endocrine system.43 The endocrine system has ten glands including: adrenal, hypothalamus, 
ovaries, pancreas, parathyroid, pineal, pituitary, testes, thymus, and thyroid gland.44 Hormones 
created in the endocrine system must find a compatible receptor in order to bind and carryout the 
instructions of the hormone.45 Hormones in reaction to a receptor can do one of two things, either 
alter an existing protein or turn on a gene to create a new protein. The main hormones of interest for 
this study were thyroid-stimulating hormone (TSH), Triiodothyronine (T3), and thyroxine  (T4). In 
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the human body, the pituitary gland creates thyroid-stimulating hormone (TSH), among other 
hormones, while T3 and T4 are created by the thyroid gland.  
 
2f. Triiodothyronine (T3) 
 
Triiodothyronine or T3 is created from a conversion of T4 in the blood. The lifespan of T3 is shorter 
than the lifespan of T4 to help ensure that T4 creates a steady flow of T3 in the body. The reference 
values of T3 are 80-190 ng/dL for those aged one or older.46 High levels of T3 can create rapid heart 
rate, insomnia, anxiety, as well as harm to the bones.47 For adults and children, T3 values greater 
than 180 ng/dL and greater than 200 ng/dL, respectively, are signs of hyperthyroidism. 
Hyperthyroidism should not be diagnosed using only a T3 test result, but a thyroid panel instead. 
Lower than average T3 levels could be due to a long-term illness, hypothyroidism, or starvation. 
 
2g. Thyroxine (T4) 
 
Thyroxine or T4 is created by the thyroid gland of the endocrine system. T4 tests are usually done on 
patients that may have hyper- or hypothyroidism or infertility problems. Some things may cause T4 
levels to increase including, birth control, estrogens, methadone, tamoxifene, steroids, androgens, 
barbiturates, and lithium. A normal range of T4 is 4.5-11.2 mcg/dL.48 Results that are below the 
normal range could be caused by many things, including hypothyroidism, long term illness, or 
malnutrition.  
 
2h. Thyroid-Stimulating Hormone (TSH) 
 
Thyroid-stimulating hormone also known as thyrotropin, is created by the pituitary gland, which is 
then sent to the thyroid gland in order to create T4 and T3. As shown in Figure 4, the pattern of 
release and flow for TSH, T3, and T4 is shown throughout the endocrine system. TSH is released in 
a diurnal pattern, which means that it is released daily with it active mainly in the daytime.49 The 
normal reference range for TSH usually depends on the health professional, but this study will use 
the American Association of Clinical Endocrinologists range of 0.2-3.0 mIU/L.50 TSH values below 
the normal range could be due to hyperthyroidism, Graves’ disease, goiter, pituitary damage, or 
taking thyroid medication. It is important to note that the normal range for thyroid test results for 
pregnant women should follow trimester specific ranges (shown in Table 2). 
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Figure 4: Release and Flow of TSH, T3, and T4 Hormones 
Adapted from Faix & Thienpont 2013.49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2i. Endocrine Disruption 
 
Endocrine disruption occurs when a body is exposed to a chemical, either natural or man-made, 
which in turn causes interference with the body’s normal endocrine system functioning, producing 
adverse effects.51 Chemicals that disrupt the endocrine system are called, endocrine-disrupting 
compounds (EDC). 52 It is important to note that some endocrine disruptors may be naturally present 
in food as phytoestrogens.23 There are many definitions of endocrine-disrupting compounds.  
  
 The EPA has defined EDC as, …exogenous agents that interfere with the production, 
 release, transport, metabolism, binding, action, or elimination of the natural hormones in  the 
 body responsible for the maintenance of homeostasis and the regulation of developmental 
 processes.53  
 
Estrogens, either natural or chemically derived, are known to increase T4-binding globulin (TBG), 
which in turn increases total T4 concentrations.12 This increase of T4 is thought to make the 
endocrine system unstable, which may lead to endocrine disruption. Endocrine disruption can occur 
TSH	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one of four ways. First, the chemical can simulate a hormone, which confuses the body into over-
responding to the stimulus. Second, the chemical can imitate the hormone and cause it to respond at 
incorrect times. Third, the chemical can block the receptors of a hormone. Finally, the chemical can 
over or under produce hormones to stimulate or hinder the system. Endocrine disruptors are thought 
to be able to bind to the estrogen receptor, which would affect the estrogen-dependent genes.5 
Another option is that parabens are similar structurally to xenobiotics, thus the estrogenicity of 
parabens may be a result of suppression of estrogen sulfotransferases (SULTs). 54 Taxvig et al, 
believes that parabens interfere with the transport of cholesterol to the mitochondria, which would 
thereby interfere with steroidogenisis.15  
 
It is important to note that some pharmaceuticals purposely create endocrine disrupting effects, such 
as birth control pills. Following the passing of the Food Quality Protection Act and the Safe 
Drinking Water Act in 1996, the EPA began screening chemicals for endocrine disruption 
capabilities under the Endocrine Disruptor Screening Program (EDSP). 55 A lack of regulation for 
parabens and other potential endocrine disrupting compounds has led to many in vivo and in vitro 
studies to examine the estrogenic effects of parabens (see table 3 in appendices). 
 
2j. Estrogenic Effects of Parabens 
 
It has been theorized that butylparaben possesses weak estrogenic effects when exposed 
subcutaneously, while another study found negative fertility effects from oral exposure to butyl- and 
propylparaben.5, 7 When the latter study was repeated with a larger study design, no effect was 
found.8, 9 Another rodent development study found that butylparaben did not affect development of 
rodent fetuses in any aspect, which led to the finding that butylparaben does not have a strong 
estrogenic effect on development.56 Some may argue that the estrogenic effects found in rodent 
studies cannot be extrapolated to humans.57 A study conducted on humans, dermally exposed 2.0% 
butylparaben on the whole body for two weeks did not have a reproductive effect.12 Another 
important study using fertility clinic data showed no evidence for a relationship between methyl-, 
propyl-, or butylparaben and altered hormone levels or sperm quality; however, it was found that 
butylparaben has greater reproductive toxicity potential.11 A nationally representative data study 
showed ethyl- and butylparaben to decrease thyroid hormone levels in females but not males.10   
 
It is thought that disease of the thyroid gland is related to breast cancer, however this has not been 
proven. Some studies have found parabens in breast cancer tissue 14, 58 and try to link parabens to 
breast cancer. However, there is no scientific basis for hypothesizing that parabens are linked to the 
development of breast cancer.59 Over recent decades an increase of breast cancer incidence has been 
correlated with the growth of personal care product use in the Western world, however it is 
important to note that other lifestyle changes have occurred during this time that could possibly 
confound correlation results.14 Another difficulty in establishing causation of parabens is that the 
harm or adverse effects may not come until many years after exposure.60  
  
	  10	  
Table 3 in the appendices, shows the various studies that have shown estrogenic effects from 
butylparaben, adapted from P.W. Harvey and D.J. Everett.61 According to Scialli, A. (2011) the 
studies each have limitations that make them unsupported, outlined in his paper.40 While the debate 
of the estrogenic effects of parabens continues, some people have disputed the possible additive or 
synergistic effect of multiple weak estrogenic compounds.62 However it has been found that 
compounds that are considered reproductive toxins have an adversity threshold, which would limit 
the additive or synergistic effects of multiple parabens.63 The long-term effects of low-level paraben 
exposure on the human body have not been studied and therefore are unknown.58 A need for further 
research on paraben human exposure is important to further understand paraben potency.  
 
2k. Smoking 
 
Smoking cigarettes has been shown to have a weak stimulatory effect on thyroid function and size.64 
Although the mechanism is unknown, it is thought that the nicotine included in tobacco products 
causes a stimulatory effect of the nervous system, which in turn increases thyroid secretion.65 Some 
studies have found TSH levels are lower in those who are smokers.66-68 Various studies have shown 
differing results for specific thyroid levels. For thyroxine (T4), cigarette smoking was shown to 
slightly elevate T4 levels 69, 70 or create no change in T4 levels.65, 71, 72 For Triiodothyronine (T4), 
cigarette smoking was shown to increase T3 levels 73, 74 or create no change in T3 levels. 71, 72 
Cigarette smoking was shown to decrease TSH levels 70, 73 or remain unaltered. 66, 75 It is important 
to note that my study looked at ever smoked data instead of current smoking data.  
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Chapter III 
Methodology 
 
 
3a. Data Source 
 
Data used in these analyses were collected from the 2007-2008 National Health and Nutrition 
Examination Survey (NHANES).76 NHANES is conducted by the Center for Disease Control and 
Prevention (CDC) as an ongoing, cross-sectional study on the health and nutrition of adults and 
children in the United States. Participants of NHANES are selected by stratified multistage 
probability sampling of the civilian non-institutionalized population of the United States.77 The first 
stage of the multistage probability sampling of NHANES began with primary sampling units 
(PSUs), which were usually counties or small groups of adjacent counties. The PSUs were selected 
with probabilities proportionate to size. During the second stage, blocks or groups of blocks were 
selected within the PSUs. For the third stage, selections of dwelling units within the census blocks 
were chosen. During the fourth and final stage, a group of individuals were chosen from the sampled 
households to complete the household interview.78 Survey information was collected through 
household interviews by trained interviewers. Physical examinations, laboratory tests, and other 
measurements were completed in mobile examination centers.  
 
3b. Study Population 
 
Of the 10,149 participants of the 2007-2008 NHANES data collection, 2,718 participants were 
chosen to be included in the one-third subsample of paraben testing. This subsample included 114 
participants with missing butylparaben data. Analyses were restricted to females 12 and over who 
were not pregnant, not taking birth control, and did not have thyroid problems, totaling to 897 
participants. A total of 957 men, 622 females under 12 years of age, 64 women taking birth control, 
20 pregnant women, 158 women with thyroid problems, and 6 with outlying values were excluded. 
Figure 5 goes into more detail for inclusion and exclusion criteria in a flow chart.  
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Figure 5. Inclusion and Exclusion Subsample Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,718	  Environmental	  Phenols	  Subsample	  
957	  Males	  Excluded	  
20	  Pregnant	  Women	  Excluded	  64	  Women	  Taking	  Birth	  Control	  Excluded	  
158	  Women	  with	  Thyroid	  Problems	  Excluded	  
622	  Females	  Under	  12	  Years	  of	  Age	  Excluded	  
6	  Females	  with	  Outlying	  Values	  Excluded	  
19	  Adolescents	  (12-­‐19)	  with	  Missing	  Thyroid	  Data	  Excluded	  
58	  Adults	  (20+)	  with	  Missing	  Data	  Excluded	  
1,761	  Females	  Only	  
1,139	  Females	  Over	  12	  Years	  of	  Age	  
891	  Females	  Over	  12	  Years	  of	  Age	  (are	  not	  pregnant,	  not	  taking	  birth	  control,	  and	  do	  not	  have	  thyroid	  problems)	  
800	  Females	  Over	  12	  Years	  of	  Age	  (are	  not	  pregnant,	  not	  taking	  birth	  control,	  do	  not	  have	  thyroid	  problems,	  and	  do	  not	  have	  missing	  data)	   663	  Adults	  (20+)	  137	  Adolescents	  (12-­‐19)	  
14	  Adolescents	  (12-­‐19)	  with	  Missing	  Smoking	  Data	  Excluded	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3c. Butylparaben and Serum Thyroid Measures 
 
Butylparaben and serum thyroid measures were measured in a one-third subsample of the dataset. 
Subsamples were done to prevent participant burnout. Mobile examination centers were used to 
collect examination and laboratory data. Butylparaben measures were collected from participants 6 
and over using spot urine samples that were stored at -20°C until analysis. Hydrolysis of the 
conjugated specimen using β-glucuronidase/sulfatase, was followed by solid phase extraction (SPE), 
reverse-phase high-performance liquid chromatography separation, and atmospheric pressure 
chemical ionization-isotope dilution and tandem mass spectrometry (MS/MS). These measure 
methods are more fully described in a previous study.42 The limit of detection (LOD) for 
butylparaben was 0.2 ug/L. Serum thyroid measures were collected from participants 12 years and 
over from the NHANES thyroid profile. The serum samples were measured with immunoenzymatic 
assays.   
 
3d. Data Analysis Overview 
 
Data analyses were performed using SAS software (version 9.2; SAS Institute, Cary, NC). SAS 
survey procedures were employed to account for the complex, multistage study design of 
NHANES.79 Results presented are weighted except where noted otherwise. Descriptive statistics 
were obtained to summarize the distribution of study variables. Butylparaben and TSH were non-
normally distributed for both the adolescent and adult age groups and was log transformed. 
Concentrations of butylparaben that were below the LOD (limit of detection) were replaced in the 
NHANES dataset with values equal to the LOD divided by the square root of two. Weighted means 
were obtained for the main independent and dependent variables of interest stratified by 
race/ethnicity group and by smoking status. Independent samples t-test and ANOVA was used to test 
whether butylparaben, TSH, T3, or T4 levels differed across race or smoking status groups. 
Weighted bivariate linear regression was performed for each independent variable with the 
dependent variable. Weighted multiple linear regressions were performed and parameter estimates 
with 95% confidence intervals were used to ascertain the relative measure of effect. Separate 
regression models stratified by age group were ran for each dependent variable (TSH, T3, and T4) 
regressed on butylparaben level and covariates, race and smoking status. An alpha=0.05 was used to 
determine statistical significance.  
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Chapter IV 
Results 
 
4a. Sample Demographics 
 
The sample of females 12 years old and over totaled to 891 participants after exclusionary criteria 
were applied. Thirty-three adolescents (12-19 years old) were omitted from the analytic sample due 
to missing data on the variables, while 58 adults (20+ years old) were excluded due to missing 
values. The final study analytic data consisted of 800 participants, with 663 in the adult (20+years 
old) age group and 137 in the adolescent (12-19 years old) age group.  
 
All analyses were done with stratified age groups and all results will be shown stratified. The 
participants ranged in age from 12 to 80 with a mean age 43.79 (SD=20.29) for the total subsample. 
The average age for adolescents was 15 (SD=2.14) while the average age for adults was 50 
(SD=16.71). Table 4 describes the racial/ethnic distribution of adolescent and adults females.  
 
Table 1: Distribution of Race/Ethnicity in Adolescent and Adult Female Study Subsamples 
 Adolescent Females N (%) Adult Females N (%) 
 
Mexican American 39 (25.83) 132 (19.91) 
Other Hispanic 27 (17.88)   86 (12.97) 
Non-Hispanic White 37 (24.50) 282 (42.53) 
Non-Hispanic Black 43 (28.48) 137 (20.66) 
Other Race- Including Multi-Racial 5 (3.31) 26 (3.92) 
a Unweighted Estimates of Race/Ethnicity 
 
Table 2: Distribution of Race/Ethnicity in Butylparaben and Thyroid Hormone 
               Subgroups Among Adolescent and Adult Female Study Subsamples 
 Adolescent Females N (%) 
 
Adult Females N (%) 
Butylparaben: 170 721 
     Mexican American 43 (25.29) 139 (19.28) 
     Other Hispanic 28 (16.47)  88 (12.21) 
     Non-Hispanic Black 41 (24.12) 294 (40.78) 
     Non-Hispanic White 53 (31.18) 171 (23.72) 
     Other Race-Including Multi-Racial 5 (2.94) 29 (4.01) 
   
TSH, T3, T4: 137 663 
     Mexican American 39 (25.83) 132 (19.91) 
     Other Hispanic 27 (17.88)  86 (12.97) 
     Non-Hispanic Black 37 (24.50) 282 (42.53) 
     Non-Hispanic White 43 (28.48) 137 (20.66) 
     Other Race-Including Multi-Racial 5 (3.31) 26 (3.93) 
      a
 Unweighted Estimates of Race/Ethnicity 
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4b. Descriptive Statistics  
 
As shown in Table 3, weighted means concentrations of ng/ml butylparaben, mIU/L TSH, ng/dL T3, 
and ug/dL T4 levels are shown with comparison between age and race. Among adolescent females, 
Mexican Americans had the highest mean concentration levels of butylparaben, T3, and T4. Other 
Hispanic Adolescents had the lowest mean concentration levels of butylparaben and T3. Non-
Hispanic White adolescents had the highest mean concentration levels of TSH and the lowest mean 
concentration levels of T4, whereas the other race group, which includes multi-racial races, had the 
lowest mean concentration levels for TSH.  
 
Adult female non-Hispanic Whites had the highest mean concentrations of butylparaben and TSH, 
while the other race group, which includes multi-racial races, had the lowest mean concentration 
levels of butylparaben and non-Hispanic Blacks had the lowest mean concentration levels of TSH. 
Adult Mexican Americans had the highest mean concentration levels of T3 and T4, whereas other 
race adult females, which include multi-racial races, had the lowest mean concentration levels of T3 
and T4 mean levels. 
 
The age stratified, weighted mean concentrations for TSH (mIU/L) , T3 (ng/dL), and T4 (ug/dL) 
between adolescents who ever smoked and those who did not as well as adults who have smoked at 
least 100 cigarettes and those who have not are presented in Table 4.  
 
 
 
Table 3: Weighted Means of Butylparaben, TSH, T3, and T4 for Adolescent and Adult Females by 
Race/Ethnicity Groups 
 Mean (95% Confidence Interval) 
  Butylparaben 
(log ng/ml) 
TSH  
(log mIU/L) 
T3 
(ng/dL) 
T4 
(ug/dL) 
 
Adolescent Females (12-19)  0.25 (0.10-0.65) 2.06 (1.54-2.75) 121.65 (117.28-126.01) 7.44 (7.25-7.62) 
Mexican American  0.96  (0.14-6.43) 1.71 (1.20-2.43) 130.16 (115.28-145.04) 8.19 (7.65-8.74) 
Other Hispanic  0.08 (0.03-0.28) 1.60 (0.79-3.25) 125.51 (116.57-134.46) 7.67 (7.37-7.98) 
Non-Hispanic Black  0.19 (0.05-0.65) 2.80 (2.15-3.63) 121.24 (115.48-126.99) 7.12 (6.93-7.31) 
Non-Hispanic White 0.28 (0.15-0.49) 1.49 (1.10-2.02) 116.74 (111.86-121.62) 7.64 (7.36-7.91) 
Other Race- Including Multi-Racial  1.61 (0.14-18.2) 0.45 (0.06-3.31) 114.47 (98.14-130.79) 8.07 (7.50-8.65) 
 
     
Adult Females (20+)  1.40 (0.98-2.00) 3.06 (2.39-3.91) 108.10 (105.19-111.01) 7.63 (7.43-7.82) 
Mexican American  0.61 (0.30-1.24) 3.15 (2.29-4.33) 113.46 (108.01-118.91) 8.11 (7.81-8.41) 
Other Hispanic  2.57 (1.53-4.31) 2.90 (1.96-4.30) 112.64 (107.34-117.94) 7.92 (7.42-8.43) 
Non-Hispanic Black 1.78 (1.01-3.13) 3.39 (2.52-4.57) 107.01 (103.06-110.97) 7.52 (7.25-7.78) 
Non-Hispanic White 0.51 (0.23-1.17) 1.85 (1.62-2.11) 109.16 (104.22-114.10) 7.75 (7.50-8.01) 
Other Race- Including Multi-Racial 1.33 (0.16-11.2) 2.62 (1.06-6.47) 106.77 (99.62-113.95) 7.66 (7.24-8.08) 
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Table 4: Weighted Means of Butylparaben, TSH, T3, and T4 for Adolescent and Adults Female Smokers 
and Non-Smokers 	   Adolescent	  Females	  (12-­‐19)	   Adult	  Females	  (20+)	  
Smoking	  (Yes)	   Smoking	  (No)	   Smoking	  (Yes)	   Smoking	  (No)	  
     
TSH Mean [log mIU/L]  
(95% CI) 	   2.61 (1.41-4.82)	   1.95 (1.35-2.82)	   2.61 (1.78-3.57)	   3.43 (2.70-4.36)	  
T3 Mean [ng/dL]  
(95% CI) 	   121.77 (114.71-128.82)	   122.51 (116.36-128.65)	   110.43 (106.00-109.71)	   106.42 (103.13-109.71)	  
T4 Mean [ug/dL]  
(95% CI) 	   7.51 (7.11-7.92)	   7.41 (7.13-7.69)	   7.57 (7.39-7.75)	   7.67 (7.42-7.92)	  
Butylparaben Mean [log ng/ml] 
(95% CI) 	   0.32 (0.12-0.89)	   0.19 (0.09-0.44) 1.12 (0.57-2.20)	   1.61 (0.96-2.69)	  a	  Adolescent	  Smoking	  question:	  Have	  you	  ever	  smoked	  before?	  b	  Adult	  Smoking	  question:	  Have	  you	  smoked	  at	  least	  100	  cigarettes	  in	  lifetime?	  
	  
	  
4c. Bivariate Analysis	  
 
Weighted bivariate regression analysis was performed for TSH, T3, and T4 separately for adolescent 
and adults females. Table 6, shows bivariate weighted regression coefficients with 95% confidence 
intervals. Among adult females, a one-ng/ml increase in butylparaben was associated with a -1.07 
decrease ng/dL in T3 (p<. 05). Among adult females, a one-ng/ml increase in butylparaben was 
associated with a -0.12 decrease ug/dL in T4 (p<. 01). Butylparaben level was not predictive of TSH 
(p=. 15), T3 (p=. 79), or T4 (p=. 07) levels in adolescent females, whereas butylparaben levels in 
adult females was not predictive of TSH (p=. 55) levels. 
 
Table 5: Weighted Regression of TSH, T3, and T4 on Butylparaben for Adolescent and Adult  
               Females  
 β (95% CI) 
 *Butylparaben (log ng/ml) 
 
Adolescent Females (12-19)  
TSH (log mIU/L) -0.29 (-0.68-0.10) 
T3 (ng/dL) -0.00 (-0.01-0.01) 
T4 (ug/dL)  0.24  (-0.01-0.50) 
  
Adult Females (20+)  
TSH (log mIU/L) -0.05 (-0.24-0.13) 
T3 (ng/dL) -1.05 (-2.05- -0.04)* 
T4 (ug/dL) -0.20 (-0.30- -0.09)** 
  
           *p< .05 
           **p<. 01 
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4d. Multivariate Analysis 
Six multiple regression analyses were performed. Butylparaben was the exposure variable, and TSH, 
T3, and T4 were the outcome variables, with smoking and race as controlling variables. The multiple 
regression analyses were performed separately for adolescent females (12-19) and adult females 
(20+). Results of the multivariate regressions stratified by age group are presented in Tables 6-8.  
 
 4d1. Thyroid Stimulating Hormone (TSH) 
 
a. Adolescent Females (12-19 years) 
 TSH levels for Other Hispanic adolescent females had 0.3 mIU/L higher than the average of 
 all racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben 
 (p=. 10) and smoking (p=. 40) were not associated with TSH level change. Mexican 
 American (p=. 57), non-Hispanic White (p=. 59) and non-Hispanic Black (p=. 48) 
 race/ethnicities were not associated with TSH level changes among adolescent females. 
 
b. Adult Females (20+ years) 
 TSH levels for Mexican American adult females were 0.17mIU/L lower than the average of 
 all racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 01). TSH levels 
 for other Hispanic adult females were 0.12mIU/L higher than the average of all racial/ethnic 
 groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben (p=. 30) and 
 smoking (p=. 07) were not associated with TSH level change. Non-Hispanic White (p=. 79) 
 and non-Hispanic Black (p=. 41) race/ethnicities were not associated with TSH level changes 
 among  adult females. 
 
 
Table 6: Weighted Regression of TSH (log mIU/L) on Butylparaben (log ng/ml) and Covariates 
Independent Variables Adolescent Females (12-19) 
N=137 
Adult Females (20+) 
N=663 
 β (95%CI)  
 
Butylparaben  
 
-0.05 (-0.10-0.01) 
 
-0.01 (-0.04-0.01) 
Smoking 0.14 (-0.20-0.47) -0.14 (-0.30-0.01) 
Mexican American 0.07 (-0.17-0.30)       -0.17 (-0.26- -0.07)** 
Other Hispanic  0.30 (0.03-0.57)*   0.12 (0.00-0.24)* 
Non-Hispanic Black  0.06 (-0.19-0.32)  0.02 (-0.16-0.20) 
Non-Hispanic White  0.09 (-0.18-0.36)  0.05 (-0.07-0.17) 
 
F  7.46 7.25 
df 6, 16 6, 16 
R2 (adjusted R2) 0.12 (0.11) 0.025 (0.022) 
p  <. 0001* <. 0001* 
*p<. 05 
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 4d2. Triiodothyronine (T3) 
 
a. Adolescent Females (12-19 years) 
 None of the covariates in the model significantly changed T3 levels. Butylparaben  
 (p=. 66), smoking (p=. 83), Mexican American (p=. 12), other Hispanic (p=. 74), non- 
 Hispanic White (p=. 39), and non-Hispanic Black (p=. 83) races/ethnicities were not  
 associated with changes in T3 levels among adolescent females.  
 
 
b. Adult Females (20+ years) 
 T3 levels for other Hispanic adult females were 0.03 ng/dL lower than the average of all 
 racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben 
 (p=. 12), smoking (p=. 16), Mexican American (p=. 54), non-Hispanic White (p=. 12), and 
 non-Hispanic Black (p=. 16) races/ethnicities were not associated with change in T3 levels 
 among adult females.  
 
 
 
Table 7: Weighted Regression of T3 (ng/dL) on Butylparaben (log ng/ml) and Covariates 
Independent Variables Adolescent Females (12-19) 
N=137 
Adult Females (20+)  
N=663 
 β (95%CI) 
 
Butylparaben -0.51 (-2.88-1.86)    -0.01 (-0.02-0.00) 
Smoking  -1.03 (-10.99-8.94)     0.04 (-0.02-0.09) 
Mexican American  -6.14 (-14.15-1.88)    -0.01 (-0.06-0.03) 
Other Hispanic -1.12 (-8.08-5.84)        -0.03 (-0.06- -0.00)* 
Non-Hispanic Black    3.74 (-5.32-12.80)     0.03 (-0.01-0.07) 
Non-Hispanic White    9.49 (-10.99-8.94)     0.03 (-0.01-0.07) 
 
F 2.64 8.08 
df 6, 16 6, 16 
R2 (adjusted R2) 0.05 (0.03) 0.028 (0.025) 
p  0.0165* <. 0001* 
 *p<. 05 
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 4d3. Thyroxine (T4) 
 
a. Adolescent Females (12-19 years) 
 T4 levels for other Hispanic adolescent females were 0.67 ug/dL lower than the average of 
 all racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 0001). T4 levels 
 for Non-Hispanic White adolescent females were 0.44 ug/dL higher than the average of all 
 racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben 
 (p=. 18), smoking (p=. 84), Mexican American (p=. 34), and non-Hispanic Black (p=. 77) 
 racial/ethnic groups were not associated with change in T4 levels among adolescent females. 
 
b. Adult Females (20+ years) 
 Adult female T4 levels were 0.12 ug/dL lower than average with increased butylparaben 
 exposure, adjusting for butylparaben, smoking, and race (p<. 01). Smoking (p=. 51), 
 Mexican American (p=. 47), non-Hispanic Black (p=. 05), and non-Hispanic White (p=. 40) 
 racial/ethnic groups were not associated with change in T4 levels among adolescent females.  
 
 
 
 
Table 8: Weighted Regression of T4 (ug/dL) on Butylparaben (log ng/ml) and Covariates 
Independent Variables Adolescent Females (12-19) 
N=137 
Adult Females (20+) 
N=663 
 β (95%CI) 
 
Butylparaben   0.13 (-0.07-0.33)       -0.12 (-0.19- -0.05)** 
Smoking   0.07 (-0.60-0.74) -0.07 (-0.29-0.15) 
Mexican American  -0.14 (-0.45-0.16) -0.08 (-0.30-0.14) 
Other Hispanic          -0.67 (-0.93- -0.42)*** -0.24 (-0.50-0.02) 
Non-Hispanic Black   0.06 (-0.39-0.52) 0.17 (-0.24-0.57) 
Non-Hispanic White    0.44 (0.07-0.81)* 0.28 (-0.01-0.57) 
 
F  9.09 10.52 
df 6, 16 6, 16 
R2 (adjusted R2) 0.15 (0.13) 0.04 (0.03) 
p  <. 0001* <. 0001* 
*p<. 05 
**p<. 01 
***p< .0001 
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Chapter V 
Discussion and Conclusion 
 
In this analysis of data from 2007- 2008 NHANES exposure to butylparaben and hormone levels 
(TSH, T3, and T4), bivariate results among adult females found that, butylparaben was associated 
with decreases in T3 among adult females, but not associated with change in T3 among adolescent 
females. Butylparaben was associated with decreases in T4 among adult females, but was not 
associated with change in T4 among adolescent females. No association was found for TSH change 
from increased butylparaben levels in adolescent or adult females. Multivariate results show 
butylparaben associated with a decrease in T4 levels among adult females but not with adolescent 
females, adjusting for race and smoking. Butylparaben was not associated with increased TSH or T3 
levels for adolescent or adult females. TSH levels for Mexican American adult females were higher 
than the average of all racial/ethnic groups, adjusting for butylparaben, smoking, and race. TSH 
levels for other Hispanic adolescent females were higher than the average of all racial/ethnic groups, 
adjusting for butylparaben, smoking, and race. T3 and T4 levels for other Hispanic adolescent 
females were lower than the average of all racial/ethnic groups, adjusting for butylparaben, smoking, 
and race. T4 levels for Non-Hispanic White adolescent and adult females were higher than the 
average of all racial/ethnic groups, adjusting for butylparaben, smoking, and race. Smoking and non-
Hispanic Black race/ethnicity was not associated with changes in thyroid levels in any multivariate 
model. The adolescent female group for this study showed differing results to adult females. Among 
adolescent and adult females butylparaben, TSH, T3, and T4 variation was found among the race 
classifications. Smoking did not present an association to any of the thyroid hormone levels in 
adolescent or adult females. Though smoking did not show an association in either of the age groups, 
we did find weighted mean differences for TSH, T3, T4, and butylparaben among those who smoked 
and those who did not smoke as mentioned previously in the descriptive statistics section of the 
results. 
 
To the best of my knowledge, two studies have been done to which I could compare some of my 
findings.10, 31 Koeppe et al. studied the association of urinary triclosan and paraben concentrations 
with serum thyroid measures using the same NHANES 2007-2008. His study included both males 
and females, and the use of paraben measures adjusted for creatinine in analyses. Calafat et al. 
studied paraben concentrations in NHANES 2005-2006. Koeppe et al. and Calafat et al. did not 
calculate geometric means of butylparaben due to high percentages of values below the LOD, while 
Calafat et al. did not conduct multivariate analysis due to high percentage of values below the LOD. 
10, 41 The large amount of values below the LOD in my study may have created misrepresented 
means for butylparaben. The only study to which I can compare my multivariate results is from 
Koeppe et al. The final regression models of Koeppe et al. included covariates, age, sex, BMI, and 
urinary creatinine. My study did not examine BMI or urinary creatinine. Creatinine levels are used to 
measure kidney function, and it was not clear why these measures were included in the analyses of 
Koeppe et al. study. 80 Among adolescents and adults of both genders, the study found no significant 
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associations for T3 and T4 levels with increased levels of butylparaben. Among adolescent females 
no significant associations were found for T3 and T4 levels with increased butylparaben levels. 
Among adult females, evidence of an inverse association for ln-Free T3 levels with increased 
butylparaben levels.10 My study used total T3 and T4, whereas, Koeppe et al. study used both free 
and total T3 and T4. Lack of comparison between studies is due to differences in variables and 
models used for analyses. 
 
Hollowell et al. studied serum TSH, T4, and thyroid antibodies from 1988 to 1994 in the NHANES 
III survey. This study found that TSH level among non-Hispanic blacks was lower than that of non-
Hispanic whites, as well as T4 levels among Mexican Americans being higher than that of non-
Hispanic Whites. 31 Hollowell et al. believed that environmental factors, such as, region, poverty 
status, and urban versus rural residence, may have been playing a role in differences between 
racial/ethnic groups.29 Differences in race/ethnic thyroid levels may also be due to the cultural 
differences between race/ethnic groups, such as behaviors, beliefs, or traditions. My study also found 
many race/ethnic groups associated with changes in thyroid hormone levels. It is unclear why race is 
associated with changes in thyroid levels. A study by McLeod examining thyroid-related disease 
among U.S. military personnel from 1997 to 2011, found thyroid levels varied across race groups. 
McLeod was uncertain on whether the racial differences were caused by genetics, environmental 
exposure, or a combination of both. 81 Future analyses should account for environmental factors such 
as region, poverty status, SES, urban vs. rural location, as well as cultural differences. 
 
Meeker et al. studied urinary concentrations of parabens and serum hormone levels, semen quality 
parameters, and sperm damage from fertility clinic data. They found no evidence for an association 
between parabens (methylparaben, propylparaben, and butylparaben) with altered hormone levels or 
semen quality parameters.11 They also found that increased levels of butylparaben were associated 
with sperm DNA damage. BMI of participants was associated with higher levels of parabens 
concentrations, possibly due to an increase to exposure. 
 
While few human studies have found associations for change in thyroid hormone levels from 
increased levels of butylparaben10, several rodent studies have found associations for estrogenic 
effects of increased butylparaben.4, 6, 19, 54 Rodent effects of butylparaben exposure included birth 
defects, uterotrophic capacity, reproductive toxicity, and developmental toxicity. A list of studies 
finding estrogenic effects from butylparaben exposure can be found in the appendices.  A rodent 
study by Daston, found no effects of butylparaben on development, while it did produce maternal 
toxicity in rats at exposure doses up to 1000mg/kg/day.56 A rodent study by Hossaini et al. found a 
lack of estrogenic effects from butylparaben exposure to mice.21 Conflicting results can be seen 
among rodent studies, some find estrogenic effects while others find a lack of estrogenic effects. It is 
important to look at if/how the rodent study results could be applied to humans. Some may argue 
that the estrogenic effects found in rodent studies cannot be extrapolated to humans.57 
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5a. Strengths 
 
The use of a nationally representative study increases the generalizability of the results. To my 
knowledge, this is the first study to investigate butylparaben level associated with thyroid hormone 
levels (TSH, T3, T4) in a female only study design. Exclusion of pregnant women, women taking 
birth control, as well as women with thyroid problems help to limit confounding effects of known 
thyroid increasing properties. Stratifying analyses by age groups, adolescent’s age 12 to 19 years and 
adults age 20 years and over helped to reduce bias due to differing thyroid activity in younger and 
older ages.  
 
5b. Limitations 
 
The lack of associations in the adolescent female age group may have been due to the smaller 
sample size. The adolescent female sample size was only 151 whereas the adult female sample size 
was much large at 663. It is also possible that adolescents excrete lower levels of thyroid hormones 
and are therefore more difficult to detect associations in thyroid levels. Among adolescent females 
66 (39%) participants had butylparaben levels below the limit of detection (LOD), while adults had 
256 (36%) participants with butylparaben levels below the LOD. As described in the methodology 
section butylparaben levels below the LOD would be replaced with the LOD divided by the square 
root of two (0.14). For both adolescent and adult females, butylparaben levels below the LOD made 
up the largest percentages of values; this may have been the reason for the skewness of the 
butylparaben variable. Causation cannot be established due to the use of data from NHANES, an 
observational, cross-sectional study. Butylparaben was measured using a spot urine test. Parabens 
are known to have a short half-life, however three recent studies show that timing of the urine spot 
test do not affect the accuracy of paraben representation.41, 82, 83  
 
5c. Future Study 
 
It is still debated whether parabens are endocrine/thyroid disruptors. As of now, parabens are not 
considered endocrine disruptors, yet some studies have shown associations of parabens with changes 
in thyroid hormone levels. Studies are needed that explain the absorption and metabolism of 
parabens and their effects or lack of effects on thyroid hormone levels. Previous studies researching 
these topics have only been done in rodent populations (see table 3 in appendices). As mentioned 
earlier multiple parabens are usually used products and thus research needs to be done to show the 
effects of the combined parabens on thyroid hormone levels. Case-control studies could be used to 
study the possible synergistic effects of parabens on the human body. Cohort studies would be useful 
in studying the long-term effects of parabens on the human body. It is unclear why race is associated 
with increases and decreases of butylparaben, TSH, T3, and T4 levels. Future study on racial effects 
of parabens on thyroid hormone levels is needed to better understand the differences between races. 
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A randomized controlled study (RCT) could be used to study the cause of thyroid differences in 
race/ethnicities.  
 
5d. Conclusion 
 
In conclusion, the present analysis examined the relationship between butylparaben and thyroid 
hormone levels among a female only study design using a large, representative sample of the U.S. 
adolescent and adult female population. NHANES data from 814 females aged 12 and over who 
were not pregnant, not taking birth control, and did not have thyroid problems increased the 
generalizability of findings. I observed significant association between butylparaben and decreases 
in T4 thyroid hormone levels among adult females, as well as several associations both positive and 
negative between race categories and thyroid hormone levels in adolescent and adult females. While 
parabens are currently not considered endocrine disruptors, the human metabolism of and affects 
from exposure to parabens are not well understood. Results from this study showed decreased levels 
of T4 thyroid hormone levels associated with increased levels of butylparaben, as well as differences 
in thyroid hormone levels among racial/ethnic groups. The results of this study indicating no 
statistically significant association between butylparaben and decreases in thyroid hormone levels 
are consistent with results of some rodent studies finding a lack of estrogenic effects of parabens. 9, 
20, 54 Although not many human studies have found significant results, 10 some rodent studies have 
found paraben associations with adverse health effects.5, 7, 56 These results, in accordance with the in 
vitro and in vivo literature, suggest that butylparaben exposure may not be associated with altered 
thyroid hormone levels in humans. Additional human studies with paraben and thyroid hormone 
levels are needed to confirm these potential significant findings.  
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Appendices 
 
Table 9: Parabens and Synonymous Names 
Methylparaben 
Benzoic Acid, 4-Hydroxy-, Methyl Ester 
p-Carbomethoxyphenol 
4-Hydroxybenzoic Acid, Methyl Ester 
p-Methoxycarbonylphenol 
Methyl-4-Hydroxybenzoate 
Methyl p-hydroxybenzoate 
Methyl Parahydroxybenzoate 
Parahydroxybenzoate Ester 
Ethylparaben 
Benzoic Acid, 4-Hydroxy-, Ethyl Ester 
Ethyl p-hydroxy benzoate 
Ethyl 4-Hydroxybenzoate 
Ethyl p-Hydroxybenzoate 
Ethyl Parahydroxybenzoate 
4-Hydroxybenzoic Acid, Ethyl Ester 
Parahydroxybenzoate Ester 
Propylparaben 
Benzoic Acid, 4-Hydroxy-, Propyl Ester 
4-Hydroxybenzoic Acid, Propyl Ester 
Parahydroxybenzoate Ester 
Propyl p-hydroxybenzoate 
Propyl p-Hydroxybenzoate 
Propyl Parahydroxybenzoate 
Isopropylparaben 
Benzoic Acid, 4-Hydroxy-, 1-Methylethyl 
Ester 
p-Hydroxybenzoic Acid, Isopropyl Ester 
4-Hydroxybenzoic Acid, 1-Methylethyl Ester 
Isopropyl p-Hydroxybenzoate 
1-Methylethyl-4-Hydroxhybenzoate 
Parahydroxybenzoic Acid, Isopropyl Ester 
Butylparaben 
Benzoic Acid, 4-Hydroxy-, Butyl Ester 
Butyl 4-Hydroxybenzoate 
Butyl p-Hydroxybenzoate 
Butyl p-hydroxy benzoate 
Butyl Parahydroxybenzoate 
Parahydroxybenzoate Ester 
Isobutylparaben 
Benzoic Acid, 4-Hydroxy-, 2-Methylpropyl 
Ester 
4-Hydroxybenzoic Acid, 2-Methylpropyl 
Ester 
Isobutyl p-Hydroxybenzoate 
Isobutyl Parahydroxybenzoate 
Parahydroxybenzoic Acid, Isobutyl Ester 
Benzylparaben 
Benzoic Acid, 4-Hydroxy-, Phenylmethyl 
Ester 
Benzyl p-Hydroxybenzoate 
Benzyl Parahydroxybenzoate 
4-Hydroxybenzoic Acid, Benzyl Ester 
Phenylmethyl 4-Hydroxybenzoate 
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Table 10: Trimester Specific T3, T4, and TSH Hormone Ranges during Pregnancy 
 
 First Trimester Second Trimester Third Trimester 
FT3 pmol/L 10-18 9-16 8-14 
FT4 pmol/L 3.4-6.6 3.2-6.2 3.2-5.6 
TSH mU/L <0.01-3.4 1.3-3.3 1.2-3.5 
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Table 11: Butylparaben Studies with Estrogenic Results 
 
Butylparaben	  
Result	   Reference	  In	  vivo	  (rat	  birth	  defects)	   21	  In	  vitro	  (yeast	  C	  receptor	  binding)	   18	  In	  vitro	  (human	  MCF7)*	   19	  In	  vitro	  (human	  MCF7)	   58	  In	  vitro	  (rat	  uterus	  receptor	  binding)	   59	  In	  vivo	  (rat	  uterotrophic)	   18	  In	  vivo	  (rat	  uterotrophic)	   20	  In	  vivo	  (rat	  reproductive	  toxicity)	   52	  In	  vivo	  (mouse	  reproductive	  toxicity)	   60	  In	  vivo	  (rat	  development	  and	  reproductive	  toxicity)	   61	  In	  vivo	  (rat	  uterotrophic)	   59	  In	  vivo	  (mouse	  uterotrophic)	   59	  *MCF7	  is	  a	  hormone-­‐responsive	  breast	  cancer	  cell	  line	  
 
